Medigene AG Statistics

Total Valuation

Medigene AG has a market cap or net worth of EUR 1.97 million. The enterprise value is -9.51 million.

Market Cap	1.97M
Enterprise Value	-9.51M

Important Dates

The next estimated earnings date is Friday, August 15, 2025.

Earnings Date	Aug 15, 2025
Ex-Dividend Date	n/a

Share Statistics

Medigene AG has 14.74 million shares outstanding. The number of shares has increased by 2.65% in one year.

Current Share Class	14.74M
Shares Outstanding	14.74M
Shares Change (YoY)	+2.65%
Shares Change (QoQ)	+5.09%
Owned by Insiders (%)	0.49%
Owned by Institutions (%)	2.33%
Float	14.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.26
PB Ratio	0.10
P/TBV Ratio	0.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.60
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.64

Financial Position

The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.13.

Current Ratio	2.39
Quick Ratio	2.22
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	-0.17
Interest Coverage	-28.34

Financial Efficiency

Return on equity (ROE) is -63.93% and return on invested capital (ROIC) is -34.49%.

Return on Equity (ROE)	-63.93%
Return on Assets (ROA)	-27.15%
Return on Invested Capital (ROIC)	-34.49%
Return on Capital Employed (ROCE)	-69.20%
Revenue Per Employee	85,586
Profits Per Employee	-183,138
Employee Count	76
Asset Turnover	0.21
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -95.36% in the last 52 weeks. The beta is 1.17, so Medigene AG's price volatility has been higher than the market average.

Beta (5Y)	1.17
52-Week Price Change	-95.36%
50-Day Moving Average	0.88
200-Day Moving Average	1.50
Relative Strength Index (RSI)	23.20
Average Volume (20 Days)	54,064

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medigene AG had revenue of EUR 7.45 million and -15.93 million in losses. Loss per share was -1.26.

Revenue	7.45M
Gross Profit	5.95M
Operating Income	-15.42M
Pretax Income	-15.62M
Net Income	-15.93M
EBITDA	-14.78M
EBIT	-15.42M
Loss Per Share	-1.26

Full Income Statement

Balance Sheet

The company has 14.02 million in cash and 2.55 million in debt, giving a net cash position of 11.48 million or 0.78 per share.

Cash & Cash Equivalents	14.02M
Total Debt	2.55M
Net Cash	11.48M
Net Cash Per Share	0.78
Equity (Book Value)	19.66M
Book Value Per Share	1.33
Working Capital	9.10M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -14.17 million and capital expenditures -621,000, giving a free cash flow of -14.79 million.

Operating Cash Flow	-14.17M
Capital Expenditures	-621,000
Free Cash Flow	-14.79M
FCF Per Share	-1.00

Full Cash Flow Statement

Margins

Gross margin is 79.94%, with operating and profit margins of -207.04% and -213.98%.

Gross Margin	79.94%
Operating Margin	-207.04%
Pretax Margin	-209.76%
Profit Margin	-213.98%
EBITDA Margin	-198.51%
EBIT Margin	-207.04%
FCF Margin	n/a

Dividends & Yields

Medigene AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.65%
Shareholder Yield	-2.65%
Earnings Yield	-809.82%
FCF Yield	-751.93%

Stock Splits

The last stock split was on August 29, 2024. It was a reverse split with a ratio of 0.5.

Last Split Date	Aug 29, 2024
Split Type	Reverse
Split Ratio	0.5

Scores

Medigene AG has an Altman Z-Score of -22.4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-22.4
Piotroski F-Score	n/a